These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16006110)

  • 1. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J; Planagumà A
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):277-82. PubMed ID: 16006110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosanoids in asthma.
    Wan KS; Wu WF
    Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and lipoxins.
    Fierro IM
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):271-5. PubMed ID: 15982864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
    O'Meara SJ; Rodgers K; Godson C
    Rev Physiol Biochem Pharmacol; 2008; 160():47-70. PubMed ID: 18481030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils.
    Vachier I; Chanez P; Bonnans C; Godard P; Bousquet J; Chavis C
    Biochem Biophys Res Commun; 2002 Jan; 290(1):219-24. PubMed ID: 11779156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxins: resolutionary road.
    Maderna P; Godson C
    Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins: regulators of resolution.
    Ryan A; Godson C
    Curr Opin Pharmacol; 2010 Apr; 10(2):166-72. PubMed ID: 20226737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxins: endogenous regulators of inflammation.
    McMahon B; Godson C
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F189-201. PubMed ID: 14707005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.